01 Jul 2022
Antibody responses to SARS-CoV-2 variants in the context of high seroprevalence
WHEN
25 Jul 2022
4.00 - 5.00pm (AEST)
WHERE
Hybrid: Doherty Institute Auditorium and Zoom
Doherty Seminar Series
Professor Penny Moore, University of the Witwatersrand, presents Antibody responses to SARS-CoV-2 variants in the context of high seroprevalence
Biography:
Professor Penny Moore is the South African Research Chair of Virus-Host Dynamics, Research Professor at the University of the Witwatersrand and the National Institute for Communicable Diseases (NICD) and Director of the Antibody Immunity Research Unit, an extramural unit of the SA Medical Research Council (SAMRC). She holds a joint appointment as Honorary Senior Scientist in Virus-Host Dynamics at the Centre for the AIDS Programme of Research (CAPRISA), University of Kwazulu-Natal and is Adjunct Member of the Institute of Infectious Disease and Molecular Medicine (IDM) at the University of Cape Town.
She directs a team of more than 15 scientists and 10 postgraduate students who work in the field of HIV and SARS-CoV-2 vaccine discovery, combining Virology, Immunology and Bioinformatics. Her research is funded by the NIH, the SA Medical Research Council, the International AIDS Vaccine Initiative, the SA National Research Foundation and the Bill and Melinda Gates Foundation. In the past 18 years, she has contributed towards more than 130 papers, focusing predominantly on HIV and SARS-CoV-2 neutralizing antibodies and their interplay with the evolving virus, a result of extensive collaborations within South Africa and internationally. She has an H-factor of 39 and holds a NRF B1 rating. She has a very strong focus on mentorship and capacity development and supervises several postgraduate students and post-doctoral fellows within her lab and across other institutes.
Joining via Zoom?
Zoom link: https://protect-au.mimecast.com/s/gZFMCp8AxKsn2WQmLFPH546?domain=unimelb.zoom.us
ID: 861 6890 8210
Password: 626811